Polymyalgia rheumatica echocardiography and ultrasound: Difference between revisions
m (Ssharfaei moved page Polymyalgia rheumatica echocardiography or ultrasound to Polymyalgia rheumatica echocardiography and ultrasound) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | {{CMG}} {{AE}} {{Rim}}, {{AEL}} | ||
{{Polymyalgia rheumatica}} | {{Polymyalgia rheumatica}} | ||
Revision as of 18:54, 8 May 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2], Ahmed Elsaiey, MBBCH [3]
|
Polymyalgia Rheumatica Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Polymyalgia rheumatica echocardiography and ultrasound On the Web |
|
American Roentgen Ray Society Images of Polymyalgia rheumatica echocardiography and ultrasound |
|
FDA on Polymyalgia rheumatica echocardiography and ultrasound |
|
CDC on Polymyalgia rheumatica echocardiography and ultrasound |
|
Polymyalgia rheumatica echocardiography and ultrasound in the news |
|
Blogs on Polymyalgia rheumatica echocardiography and ultrasound |
|
Risk calculators and risk factors for Polymyalgia rheumatica echocardiography and ultrasound |
Overview
Ultrasound exam is important for the diagnosis of polymyalgia rheumatica (PMR). It can reveal evidence of bursitis, synovitis or tenosynovitis in the affected areas.
Ultrasound
- Ultrasound of the affected joint might reveal one or more of the following:[1]
- Subdeltoid bursitis
- Biceps tenosynovitis
- Glenohumeral synovitis (either posterior or axillary)
- Synovitis and/or trochanteric bursitis
- Findings on ultrasound are part of the PMR diagnostic criteria scoring established by the European League Against Rheumatism and the American College of Rheumatology.[1]
- Ultrasound can be useful in monitoring the patients' response to the corticosteroid treatment and detecting any subclinical inflammation.[2]
- A study revealed that [[ultrasound] can potentially help identifying patients with high inflammation who are at elevated risk of relapses or recurrences.[3]
References
- ↑ 1.0 1.1 Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C; et al. (2012). "2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative". Ann Rheum Dis. 71 (4): 484–92. doi:10.1136/annrheumdis-2011-200329. PMC 3298664. PMID 22388996.
- ↑ Jiménez-Palop M, Naredo E, Humbrado L; et al. (2010). "Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica". Ann. Rheum. Dis. 69 (5): 879–82. doi:10.1136/ard.2009.113555. PMID 19773289. Unknown parameter
|month=ignored (help) - ↑ Macchioni P, Catanoso MG, Pipitone N, Boiardi L, Salvarani C (2009). "Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica". Rheumatology (Oxford). 48 (12): 1566–9. doi:10.1093/rheumatology/kep286. PMID 19808693. Unknown parameter
|month=ignored (help)